257 related articles for article (PubMed ID: 37335089)
21. Single-Cell RNA Sequencing Analysis of Gene Regulatory Network Changes in the Development of Lung Adenocarcinoma.
Yu D; Zhang S; Liu Z; Xu L; Chen L; Xie L
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189418
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
24. Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.
Zhou Y; Shi X; Chen H; Mao B; Song X; Gao L; Zhang J; Yang Y; Zhang H; Wang G; Zhuang W
Biomed Res Int; 2021; 2021():5557649. PubMed ID: 34337026
[TBL] [Abstract][Full Text] [Related]
25. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
Wei S; Xing J; Lu K; Wang K; Yu W
Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
[TBL] [Abstract][Full Text] [Related]
26. Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8+ T cells.
Zhang H; Zhang P; Lin X; Tan L; Wang Y; Jia X; Wang K; Li X; Sun D
Front Immunol; 2024; 15():1366096. PubMed ID: 38596689
[TBL] [Abstract][Full Text] [Related]
27. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma.
Zhang P; Pei S; Gong Z; Feng Y; Zhang X; Yang F; Wang W
Front Immunol; 2023; 14():1115272. PubMed ID: 36776843
[TBL] [Abstract][Full Text] [Related]
28. Microdissection of the Bulk Transcriptome at Single-Cell Resolution Reveals Clinical Significance and Myeloid Cells Heterogeneity in Lung Adenocarcinoma.
Wu H; Qin J; Zhao Q; Lu L; Li C
Front Immunol; 2021; 12():723908. PubMed ID: 34659209
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma.
Tao Y; Li Y; Liang B
Future Oncol; 2020 Aug; 16(24):1825-1837. PubMed ID: 32501723
[No Abstract] [Full Text] [Related]
30. Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Chen Z; Yang X; Bi G; Liang J; Hu Z; Zhao M; Li M; Lu T; Zheng Y; Sui Q; Yang Y; Zhan C; Jiang W; Wang Q; Tan L
Int J Biol Sci; 2020; 16(12):2205-2219. PubMed ID: 32549766
[No Abstract] [Full Text] [Related]
31. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Wang J; Zhan X
Front Immunol; 2021; 12():752643. PubMed ID: 34887858
[TBL] [Abstract][Full Text] [Related]
32. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma.
Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H
J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975
[TBL] [Abstract][Full Text] [Related]
33.
Liu L; Wang C; Li S; Qu Y; Xue P; Ma Z; Zhang X; Bai H; Wang J
Front Immunol; 2021; 12():677169. PubMed ID: 34354701
[TBL] [Abstract][Full Text] [Related]
34. Intercellular Communication-Related Molecular Subtypes and a Gene Signature Identified by the Single-Cell RNA Sequencing Combined with a Transcriptomic Analysis.
Guan P; Cai W; Wu K; Jiang F; Wu J; Zhai X; Zeng M
Dis Markers; 2022; 2022():6837849. PubMed ID: 35620271
[TBL] [Abstract][Full Text] [Related]
35. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
36. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
37. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
38. Single-cell sequencing analysis and transcriptome analysis constructed the macrophage related gene-related signature in lung adenocarcinoma and verified by an independent cohort.
Li R; Tong R; Zhang Z; Deng M; Wang T; Hou G
Genomics; 2022 Nov; 114(6):110520. PubMed ID: 36372305
[TBL] [Abstract][Full Text] [Related]
39. Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma.
Lin S; Zhou S; Han X; Yang Y; Zhou H; Chang X; Zhou Y; Ding Y; Lin H; Hu Q
Aging (Albany NY); 2023 Oct; 15(20):11508-11531. PubMed ID: 37878007
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells.
Shao MM; Zhai K; Huang ZY; Yi FS; Zheng SC; Liu YL; Qiao X; Chen QY; Wang Z; Shi HZ
PLoS One; 2023; 18(7):e0279018. PubMed ID: 37432957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
